Skip to main content

M EVD 2 (Everolimus (for Oral Suspension) 2 mg)

Pill with imprint M EVD 2 is White, Round and has been identified as Everolimus (for Oral Suspension) 2 mg. It is supplied by Mylan Pharmaceuticals Inc.

Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; renal angiomyolipoma; pancreatic cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M EVD 2

Everolimus (for oral suspension) 2 mg M EVD 2

Everolimus (for Oral Suspension)

Imprint
M EVD 2
Strength
2 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-0005
Inactive Ingredients
lactose anhydrous, butylated hydroxytoluene, croscarmellose sodium, crospovidone, hypromellose 2910, lactose monohydrate, magnesium stearate, mannitol, microcrystalline cellulose, silicon dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.